Variant report
Variant | esv3497007 |
---|---|
Chromosome Location | chr11:104316038-104320777 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:104318241..104320528-chr11:104331933..104333593,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CASP12-1 | chr11:104316596-104316740 | ENSG00000256422 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181046532 | chr11:104316050-104316051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185080516 | chr11:104316090-104316091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369826836 | chr11:104316141-104316142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552837982 | chr11:104316189-104316190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76341475 | chr11:104316207-104316208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140924889 | chr11:104316221-104316222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369981550 | chr11:104316234-104316235 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191205895 | chr11:104316288-104316289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371769823 | chr11:104316293-104316294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375051141 | chr11:104316331-104316332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533818710 | chr11:104316336-104316337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553667378 | chr11:104316339-104316340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs576763529 | chr11:104316341-104316342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545574149 | chr11:104316342-104316343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562392690 | chr11:104316356-104316357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575726635 | chr11:104316377-104316378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552772044 | chr11:104316380-104316381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573028327 | chr11:104316391-104316392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561476893 | chr11:104316465-104316466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs13377505 | chr11:104316488-104316489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182531061 | chr11:104316497-104316498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142383032 | chr11:104316518-104316519 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532883195 | chr11:104316519-104316520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34623545 | chr11:104316522-104316523 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs569483652 | chr11:104316561-104316562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564856531 | chr11:104316576-104316577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187609278 | chr11:104316577-104316578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549494953 | chr11:104316610-104316611 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs555722346 | chr11:104316622-104316623 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs575565284 | chr11:104316643-104316644 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs543849204 | chr11:104316654-104316655 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs571637129 | chr11:104316671-104316672 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs114353927 | chr11:104316702-104316703 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs563744993 | chr11:104316790-104316791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12807863 | chr11:104316839-104316840 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs553779974 | chr11:104316844-104316845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs377573680 | chr11:104316855-104316856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546304021 | chr11:104316880-104316881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559575574 | chr11:104316912-104316913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570413471 | chr11:104316934-104316935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539391327 | chr11:104316942-104316943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555897332 | chr11:104316943-104316944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191890231 | chr11:104317029-104317030 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35931429 | chr11:104317058-104317059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76292108 | chr11:104317078-104317079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183737490 | chr11:104317103-104317104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572078784 | chr11:104317105-104317106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs80003098 | chr11:104317249-104317250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369423510 | chr11:104317272-104317273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187421501 | chr11:104317292-104317293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:104314600-104323200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr11:104315000-104316800 | Enhancers | Stomach Mucosa | stomach |
3 | chr11:104316000-104320200 | Weak transcription | Fetal Heart | heart |
4 | chr11:104316800-104321400 | Weak transcription | Stomach Mucosa | stomach |
5 | chr11:104319400-104320200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr11:104320200-104320600 | Enhancers | Fetal Heart | heart |
7 | chr11:104320200-104322000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr11:104320600-104320800 | Weak transcription | Fetal Heart | heart |